VON WILLEBRAND FACTOR--CHEMICAL CHARACTERIZATION
血管性血友病因子--化学特性
基本信息
- 批准号:3340720
- 负责人:
- 金额:$ 19.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-01-01 至 1986-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This is a proposal to undertake a study of the structural features of human
von Willebrand Factor, an unusually large oligomeric glycoprotein (subunit
size ca 200,000 daltons) which play an important role in hemostasis and
blood coagulation. Particular emphasis will be given to elucidation of its
complete primary structure and to correlation of defined
substructuraldomains with its capability to bind platelets or lolagen.
Appropriate attention will be given to the identification of sites of co-
or post-translational modification, including glycosylation and disulfide
bridging. The protein will be purified in gram quantities from a
commercial Factor VIII concentrate and the number and identity to
constituent polypeptide chains will be established by chemical means. The
whole protein, before or after disulfide reduction, will be fragmented by
limited proteolysis to provide substructural domains which will be tested
for residual or modified biological function. The whole denatured protein
will aslo be cleaved at asparaginyl-glycine, aspartyl-proline, methionyl or
arginyl bonds to generate large fragments. The products of the various
cleavage reaction will be purified and subjected to sequence analysis.
Integration of these results is expected to provide the complete amino acid
sequence. Met, Trp and Cys containing peptides will be selectively
isolated and analyzed for their design potential for synthetic
oligonucleotide hybridization probes. A long-term goal of this study is to
seek the chemical basis of dysfunction in the bleeding disorders termed von
Willebrand's disease. The proposed structural analysis should provide a
chemical framework within which questions of supramolecular organization
and dysfunction can be answered in specific terms.
这是一项对人类结构特征进行研究的建议
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms.
人类血管性血友病因子的 cDNA 序列揭示了五种类型的重复结构域和五种可能的蛋白质序列多态性。
- DOI:10.1021/bi00359a014
- 发表时间:1986
- 期刊:
- 影响因子:2.9
- 作者:Shelton-Inloes,BB;Titani,K;Sadler,JE
- 通讯作者:Sadler,JE
Selective isolation of tryptophan-containing peptides by hydrophobicity modulation.
通过疏水性调节选择性分离含色氨酸的肽。
- DOI:10.1016/0003-2697(83)90288-9
- 发表时间:1983
- 期刊:
- 影响因子:2.9
- 作者:Sasagawa,T;Titani,K;Walsh,KA
- 通讯作者:Walsh,KA
Cloning of cDNA and genomic DNA for human von Willebrand factor.
克隆人血管性血友病因子的 cDNA 和基因组 DNA。
- DOI:10.1101/sqb.1986.051.01.063
- 发表时间:1986
- 期刊:
- 影响因子:0
- 作者:Sadler,JE;Shelton-Inloes,BB;Sorace,JM;Titani,K
- 通讯作者:Titani,K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KOITI TITANI其他文献
KOITI TITANI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KOITI TITANI', 18)}}的其他基金
VON WILLEBRAND FACTOR--CHEMICAL CHARACTERIZATION
血管性血友病因子--化学特性
- 批准号:
3340719 - 财政年份:1983
- 资助金额:
$ 19.59万 - 项目类别:
相似海外基金
MRI: Acquisition of an X-ray Diffractometer for Research and Training in Chemical Structure-Function Studies
MRI:购买 X 射线衍射仪用于化学结构-功能研究的研究和培训
- 批准号:
1726630 - 财政年份:2017
- 资助金额:
$ 19.59万 - 项目类别:
Standard Grant














{{item.name}}会员




